BROWNSTEIN HYATT FARBER SCHRECK, LLP for FERRING PHARMACEUTICALS INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA IVF Tax credit
Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in healthcare policy as the ultimate parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRANDT ANDERSON | — |
| EMILY FELDER | — |
| HAROLD HANCOCK | — |
| MARK L. PRYOR New | United States Senator |
| DAVID REID New | None |
| EDWARD RANDALL ROYCE New | Representative, U.S. House of Representatives |
| ADAM STEINMETZ | — |
| DEEMA TARAZI | — |
| JONATHAN TOWERS | — |
Veterans VET
Issues related to veteran's care and veteran's reproductive care
Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in veteran's care.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN TOWERS | — |
Trade (domestic/foreign) TRD
Issues related to pharmaceutical tariffs
Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in pharmaceutical tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON CUMMINGS | — |
| EMILY FELDER | — |
| JOSEPH BRADY HOWELL | — |
| TIM SHADYAC | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.